发明名称 |
METHODS OF TREATMENT USING INTRAVENOUS FORMULATIONS COMPRISING TEMOZOLOMIDE |
摘要 |
<p>Disclosed is the use of temozolomide or a pharmaceutically acceptable salt thereof for the manufacture of a formulation for the treatment of a proliferative disorder in a patient, wherein the treatment comprises administering a dose of 150 mg/m2 of temozolomide to the patient by intravenous infusion over a period of about 90 minutes, wherein the administration achieves an arithmetic maximum plasma concentration (Cmax) of temozolomide in the range of about 5.5 to about 10.6 ìg/mL and an arithmetic maximum plasma concentration (Cmax) of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide (MTIC) in the range of about 137 to about 916 ng/mL.</p> |
申请公布号 |
NZ580982(A) |
申请公布日期 |
2012.05.25 |
申请号 |
NZ20080580982 |
申请日期 |
2008.05.07 |
申请人 |
SCHERING CORPORATION |
发明人 |
ABUTARIF, MALAZ;STATKEVICH, PAUL |
分类号 |
A61K31/4188;A61P35/00 |
主分类号 |
A61K31/4188 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|